Cellectar Biosciences, Inc. (CLRB)
3.31
+0.17
(+5.41%)
USD |
NASDAQ |
Feb 13, 12:25
Cellectar Biosciences Free Cash Flow : -29.75M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Imunon, Inc. | -14.95M |
| PDS Biotechnology Corp. | -32.28M |
| ACADIA Pharmaceuticals, Inc. | 98.97M |
| Alnylam Pharmaceuticals, Inc. | 221.36M |
| Savara, Inc. | -99.27M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -4.275M |
| Cash from Financing (Quarterly) | 5.788M |
| Free Cash Flow Per Share (Quarterly) | -1.352 |
| Free Cash Flow to Equity (Quarterly) | -4.254M |
| Free Cash Flow to Firm (Quarterly) | -4.275M |
| Free Cash Flow Yield | -37.09% |